February 1, 2023Open Access
Recent progress in adipocytokine research.
Key result
Adipocyte dysfunction drives obesity-linked metabolic and cardiovascular complications via dysregulated adipocytokines.
Why the study?
Dysregulated production or secretion of adipocytokines caused by adipocyte dysfunction leads to obesity-linked metabolic and cardiovascular complications.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Adipocytokine insights may refine obesity-related CVD risk models; leaves open targeted interventions pending prospective validation.
PICO
P
Population
Obesity-linked metabolic and cardiovascular diseases
E
Exposure / Comparator
Adipocytokines
This review summarizes the functional roles of adipocytokines in metabolic and cardiovascular diseases, highlighting how adipocyte dysfunction contributes to obesity-linked complications.
Cite This Study
Ouchi et al. (2023) conducted a review in Obesity-linked metabolic and cardiovascular diseases. Adipocytokines was evaluated. Dysregulated production or secretion of adipocytokines caused by adipocyte dysfunction leads to the development of obesity-linked metabolic and cardiovascular complications.